Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics discovers and develops novel small molecule therapeutics to control the body's protein homeostasis.
Raised
$73.6M
Follow us
Alexa global traffic share
Latest funding
$3,012,271
Debt financing - 2014
$70,623,000
Venture capital (Series A) - 2008
Novartis Venture Fund NEA Fidelity Biosciences +2
Team Size
10+
Employees
Xconomy

Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO

Health